Table 1. Descriptive characteristics of patients with vulvar cancer undergoing primary surgery.
| Parameter | SII ≤866.4 | SII >866.4 | |
|---|---|---|---|
| No. of patients | 65 | 65 | |
| Age (yr) | 65.0 (54.5–78.5) | 72.0 (60.0–79.5) | |
| FIGO-stage (2009) | |||
| I | 44 (67.7) | 33 (50.8) | |
| II | 4 (6.2) | 5 (7.7) | |
| III | 15 (23.1) | 22 (33.8) | |
| IV | 2 (3.1) | 5 (7.7) | |
| Histologic grading | |||
| G1 | 20 (30.8) | 14 (21.5) | |
| G2 | 35 (53.8) | 39 (60.0) | |
| G3 | 10 (15.4) | 12 (18.5) | |
| Nodal involvement | |||
| N0 | 46 (70.8) | 37 (56.9) | |
| N1 | 19 (29.2) | 28 (43.1) | |
| ECOG | |||
| 0 | 43 (66.2) | 31 (47.7) | |
| 1 | 16 (24.6) | 22 (33.8) | |
| 2 | 3 (4.6) | 5 (7.7) | |
| 3 | 2 (3.1) | 5 (7.7) | |
| Unknown | 1 (1.5) | 2 (3.) | |
| BMI | 27.3 (23.7–31.9) | 25.6 (23.0–31.6) | |
| CRP (mg/dL) | 0.2 (0.1–0.8) | 0.6 (0.2–1.7) | |
| Time of follow-up (mon) | 28.0 (15.0–75.0) | 32.0 (13.0–69.5) | |
| Status at last follow-up | |||
| Alive with no evidence of disease | 40 (61.5) | 29 (44.6) | |
| Alive with stable disease | 4 (6.2) | 1 (1.5) | |
| Progression | 1 (1.5) | 0 (0) | |
| Deceased | 20 (30.8) | 35 (53.8) | |
Values are presented as median (interquartile range) or number (%).
BMI, body mass index; CRP, C-reactive protein (mg/dL); ECOG, Eastern Cooperative Oncology Group; FIGO, International Federation of Gynecology and Obstetrics; SII, systemic immune-inflammatory index.